Search results
Results from the WOW.Com Content Network
The free online conference runs from 10 a.m. to 12:30 p.m. Wednesday, and is sponsored by the Alzheimer's Foundation of America. Alzheimer's is one of the top causes of death in the United States ...
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1 ] and is considered to be the “gold standard” for assessing antidementia treatments.
The MMSE may help differentiate different types of dementias. People with Alzheimer's disease may score significantly lower on orientation to time and place as well as recall, compared to those who have dementia with Lewy bodies, vascular dementia, or Parkinson's disease dementia. [25] [26] [27]
The higher cut-off score has both high specificity and sensitivity and is at least five times more likely to have come from a dementia patient than without. A score of 21 or less is almost certainly diagnostic of a dementia syndrome regardless of the clinical setting. [15] It has been found to be superior to the MMSE in diagnostic utility. [16 ...
There is no such thing as a "day off" for those who care for loved ones with Alzheimer's disease or dementia. But there is help. The Alzheimer's Association Greater East Ohio Area offers a free ...
A new test may help predict who is at risk for Alzheimer's disease. ABC explains, "It measures a patient's risk of mental impairment based on several factors, including how quickly the patient can ...
Therefore, early and accurate diagnosis of dementia and staging can be essential to proper clinical care. Without the ability to reliably assess dementia across the board, the misuse of anti-dementia compounds could have negative consequences, such as patients receiving the wrong medication, or not receiving treatment in the early stages of ...
Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's, accelerating diagnosis of the brain-wasting ...